Developer docs
API playgroundTry for free, no card

Search company profiles

TD Cowen

Full company profile

uuid0002u2f

Namestring
TD Cowen
Websiteurl
cowen.eu
Company typeenum
Private
Founded yearint
2001
Descriptiontext

TD Cowen is a corporate and investment bank that delivers integrated capital markets services, operating primarily in the U.S. equity markets. The firm provides equity research coverage including analyst ratings (Buy/Hold/Sell), price targets, and sector commentary across healthcare/biotech, technology, consumer, and energy, and executes public equity transactions — acting as lead bookrunner, joint bookrunner, or co-manager — for IPOs and follow-on offerings. Recent disclosed mandates in a single month include bookrunning roles on Kardigan's $400 million IPO, IDEAYA Biosciences' $345 million offering, Absci's $100 million offering, SOPHiA GENETICS' $57.5 million offering, and Duos Technologies' $55 million registered direct offering, alongside coverage initiations such as a Buy rating on Damora Therapeutics.

The firm's revenue model combines professional services income from equity underwriting fees (structured as a percentage of gross proceeds raised on the transactions it executes) with subscription/commission-based equity research distribution to institutional investor clients. It goes to market through a sales-led motion: direct institutional sales relationships with mutual funds, hedge funds, and pension funds, supplemented by investor conferences, corporate access programs, investor dinners, and earned media distribution of analyst commentary on platforms such as Yahoo Finance and Investing.com. Customer segmentation is horizontal, with institutional investors as the primary segment and retail investors (reached via financial media) as a secondary segment.

The firm is headquartered in New York and operates as a recognized Wall Street brand, though the input data contains a firmographic conflict indicating a Berlin, Germany headquarters with 51-100 employees — an inconsistency that is unresolved within the available source material and warrants verification before relying on either set of structural facts.

Short descriptiontext

TD Cowen is a U.S. corporate and investment bank that provides equity research, analyst coverage, and capital markets underwriting services — acting as lead or joint bookrunner on IPOs and follow-on offerings — to institutional and retail investors, with a sector emphasis on healthcare/biotech and technology.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBerlin, Germany
HQ citystring
Berlin
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
equity research services, investment banking, capital markets advisory, equity underwriting, sector research coverage
Industry1 code
1Securities Borrowing & Lending (Equities/Bonds)
CodeFSACAIACPrimaryYes
NAICS code2 codes
  • Securities and Commodity Contracts Intermediation and Brokerage5231
  • Securities, Commodity Contracts, and Other Financial Investments and Related Activities523
SIC code3 codes
  • Security Brokers, Dealers & Flotation Companies6211
  • Security & Commodity Brokers, Dealers, Exchanges & Services6200
  • Commodity Contracts Brokers & Dealers6221
Product category
Corporate and Investment Banking
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Investment Banking - Equity Underwriting
TypeProfessional Services
Description

TD Cowen acts as lead bookrunner and co-bookrunner for public equity offerings including IPOs and follow-on offerings, earning underwriting fees typically structured as a percentage of gross proceeds raised.

prnewswire.com
2Equity Research
TypeSubscription Recurring
Description

TD Cowen publishes equity research including analyst ratings, price targets, and sector coverage for public companies, generating revenue through institutional client commissions and potentially subscription-based research distribution.

in.investing.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

TD Cowen is a corporate and investment bank that delivers equity underwriting services for capital markets transactions and subscription-based equity research coverage. Its offerings are targeted at issuers and investors across healthcare/biotech, technology, consumer, and energy sectors.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Analyst ratings and price targets frequently cited by major financial news outlets and investor platforms
Product and service1 record
1Equity Underwriting
CategoryInvestment Banking
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Cantor Fitzgerald runs an active equity capital markets and research franchise with substantial biotech and growth-issuer underwriting, overlapping materially with TD Cowen's deal footprint.

TypeDirect peer
Description

B. Riley is a diversified financial services firm with a broker-dealer franchise offering equity research and capital markets execution in mid- and small-cap names, a comparable boutique-scale competitor.

TypeDirect peer
Description

Canaccord Genuity is a global mid-market investment bank with strong equity research and growth-company underwriting, matching TD Cowen's research-led, mid-cap underwriting profile.

TypeBroad incumbent
Description

Raymond James is a larger, diversified financial services firm with investment banking and equity research businesses that overlap with TD Cowen but operate at substantially greater scale and breadth.

TypeBroad incumbent
Description

Goldman Sachs is a bulge-bracket global investment bank whose equity capital markets and equity research franchises compete at the high end of the same opportunities TD Cowen targets as a co-manager or bookrunner.

TypeDirect peer
Description

Benchmark is a small/mid-cap boutique investment bank focused on equity capital markets for growth companies, comparable in scale and product mix to TD Cowen's underwriting activity.

TypeDirect peer
Description

Jefferies is a full-service U.S. investment bank with deep mid-market equity research and a strong bookrunner franchise in healthcare/biotech IPOs and follow-ons, directly comparable to TD Cowen's underwriting and research model.

TypeDirect peer
Description

Piper Sandler is a U.S. middle-market investment bank with healthcare/biotech-heavy underwriting and equity research franchises, very closely aligned with TD Cowen's sector and product mix.

TypeDirect peer
Description

Stifel operates a full-service middle-market investment bank with active equity capital markets and equity research distribution, competing head-to-head with TD Cowen for institutional and corporate clients.

TypeDirect peer
Description

William Blair is a boutique U.S. investment bank with mid-market equity underwriting and a research-led distribution model, comparable in scale, business mix, and growth-stage issuer focus.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

TD Cowen

Corporate and Investment Bankingcowen.eu

TD Cowen is a U.S. corporate and investment bank that provides equity research, analyst coverage, and capital markets underwriting services — acting as lead or joint bookrunner on IPOs and follow-on offerings — to institutional and retail investors, with a sector emphasis on healthcare/biotech and technology.

What TD Cowen does

TD Cowen is a corporate and investment bank that delivers integrated capital markets services, operating primarily in the U.S. equity markets. The firm provides equity research coverage including analyst ratings (Buy/Hold/Sell), price targets, and sector commentary across healthcare/biotech, technology, consumer, and energy, and executes public equity transactions — acting as lead bookrunner, joint bookrunner, or co-manager — for IPOs and follow-on offerings. Recent disclosed mandates in a single month include bookrunning roles on Kardigan's $400 million IPO, IDEAYA Biosciences' $345 million offering, Absci's $100 million offering, SOPHiA GENETICS' $57.5 million offering, and Duos Technologies' $55 million registered direct offering, alongside coverage initiations such as a Buy rating on Damora Therapeutics.

The firm's revenue model combines professional services income from equity underwriting fees (structured as a percentage of gross proceeds raised on the transactions it executes) with subscription/commission-based equity research distribution to institutional investor clients. It goes to market through a sales-led motion: direct institutional sales relationships with mutual funds, hedge funds, and pension funds, supplemented by investor conferences, corporate access programs, investor dinners, and earned media distribution of analyst commentary on platforms such as Yahoo Finance and Investing.com. Customer segmentation is horizontal, with institutional investors as the primary segment and retail investors (reached via financial media) as a secondary segment.

The firm is headquartered in New York and operates as a recognized Wall Street brand, though the input data contains a firmographic conflict indicating a Berlin, Germany headquarters with 51-100 employees — an inconsistency that is unresolved within the available source material and warrants verification before relying on either set of structural facts.

TD Cowen firmographics

Firmographics
Name
TD Cowen
Website
https://cowen.eu
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
51–100 employees
Short description
TD Cowen is a U.S. corporate and investment bank that provides equity research, analyst coverage, and capital markets underwriting services — acting as lead or joint bookrunner on IPOs and follow-on offerings — to institutional and retail investors, with a sector emphasis on healthcare/biotech and technology.
Ownership category
akta.pro rank

TD Cowen industry classification

Industry
Product category
Corporate and Investment Banking
NAICS
Securities and Commodity Contracts Intermediation and Brokerage (5231), Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523)
SIC
Security Brokers, Dealers & Flotation Companies (6211), Security & Commodity Brokers, Dealers, Exchanges & Services (6200), Commodity Contracts Brokers & Dealers (6221)
akta.pro primary industry
Securities Borrowing & Lending (Equities/Bonds) (FSACAIAC)

Keywords

  • Equity research services
  • Investment banking
  • Capital markets advisory
  • Equity underwriting
  • Sector research coverage

Where TD Cowen is headquartered

Location

Headquarters

HQ city
Berlin
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

TD Cowen business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Investment Banking - Equity Underwriting: TD Cowen acts as lead bookrunner and co-bookrunner for public equity offerings including IPOs and follow-on offerings, earning underwriting fees typically structured as a percentage of gross proceeds raised.
  2. Equity Research: TD Cowen publishes equity research including analyst ratings, price targets, and sector coverage for public companies, generating revenue through institutional client commissions and potentially subscription-based research distribution.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

TD Cowen product offering

Product offering

Core offering

TD Cowen is a corporate and investment bank that delivers equity underwriting services for capital markets transactions and subscription-based equity research coverage. Its offerings are targeted at issuers and investors across healthcare/biotech, technology, consumer, and energy sectors.

Differentiator

Problem solved

Functional benefit

Products and services

  • Equity Underwriting

Quantifiable outcome

  • Analyst ratings and price targets frequently cited by major financial news outlets and investor platforms

Companies that use TD Cowen

Customer profile

Segments2 records

Ideal customer profiles2 records

TD Cowen technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

TD Cowen partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

TD Cowen competitors and assessment

Company assessment

Direct peers

  • Cantor Fitzgerald: Cantor Fitzgerald runs an active equity capital markets and research franchise with substantial biotech and growth-issuer underwriting, overlapping materially with TD Cowen's deal footprint.
  • B. Riley Financial: B. Riley is a diversified financial services firm with a broker-dealer franchise offering equity research and capital markets execution in mid- and small-cap names, a comparable boutique-scale competitor.
  • Canaccord Genuity: Canaccord Genuity is a global mid-market investment bank with strong equity research and growth-company underwriting, matching TD Cowen's research-led, mid-cap underwriting profile.
  • Benchmark Company: Benchmark is a small/mid-cap boutique investment bank focused on equity capital markets for growth companies, comparable in scale and product mix to TD Cowen's underwriting activity.
  • Jefferies: Jefferies is a full-service U.S. investment bank with deep mid-market equity research and a strong bookrunner franchise in healthcare/biotech IPOs and follow-ons, directly comparable to TD Cowen's underwriting and research model.
  • Piper Sandler: Piper Sandler is a U.S. middle-market investment bank with healthcare/biotech-heavy underwriting and equity research franchises, very closely aligned with TD Cowen's sector and product mix.
  • Stifel Financial: Stifel operates a full-service middle-market investment bank with active equity capital markets and equity research distribution, competing head-to-head with TD Cowen for institutional and corporate clients.
  • William Blair: William Blair is a boutique U.S. investment bank with mid-market equity underwriting and a research-led distribution model, comparable in scale, business mix, and growth-stage issuer focus.

Broad incumbents

  • Raymond James: Raymond James is a larger, diversified financial services firm with investment banking and equity research businesses that overlap with TD Cowen but operate at substantially greater scale and breadth.
  • Goldman Sachs: Goldman Sachs is a bulge-bracket global investment bank whose equity capital markets and equity research franchises compete at the high end of the same opportunities TD Cowen targets as a co-manager or bookrunner.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

TD Cowen social profiles

Digital presence

TD Cowen financial estimates

Financial estimate

Revenue estimate

Valuation estimate

TD Cowen leadership team

Management profile

Number of profiles

Profiles2 records

TD Cowen funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

TD Cowen M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TD Cowen

What does TD Cowen do?

TD Cowen is a corporate and investment bank that delivers equity underwriting services for capital markets transactions and subscription-based equity research coverage. Its offerings are targeted at issuers and investors across healthcare/biotech, technology, consumer, and energy sectors.

Is TD Cowen a public or private company?

TD Cowen is a private company. It is classified as unknown and is currently operating.

When was TD Cowen founded?

TD Cowen was founded in 2001. It employs 51 to 100 people.

Where is TD Cowen based?

TD Cowen is headquartered in Berlin, Germany, in the Europe region.

How does TD Cowen make money?

Two revenue lines are on record. Investment Banking - Equity Underwriting is the primary driver. The others are equity Research.

Who are TD Cowen's main competitors?

Direct peers on record are Cantor Fitzgerald, B. Riley Financial, Canaccord Genuity, Benchmark Company, Jefferies, Piper Sandler, Stifel Financial and William Blair. Broad incumbents are Raymond James and Goldman Sachs.

Does TD Cowen have an API?

No public API is recorded for TD Cowen.

What industry is TD Cowen in?

TD Cowen's product category is Corporate and Investment Banking. Its primary akta.pro industry code is FSACAIAC, Securities Borrowing & Lending (Equities/Bonds). Its NAICS code is 5231 and its SIC code is 6211.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Investing.comPalo Alto Networks director Bawa sells $103,070 in company stockPalo Alto Networks director Aparna Bawa sold 250 shares on October 9, 2026, for $103,070, with prices between $410 and $417.125. The stock trades at $418.78, near its 52-week high, and analysts have raised price targets, with TD Cowen at $440 and BTIG at $425.StocktwitsTD Cowen Says De-Rating In Aerospace Stocks Has Been ‘Disorderly,’ Cuts Targets On Boeing, Lockheed Martin Among OthersTD Cowen cut price targets on five aerospace and defense stocks ahead of earnings, citing disorderly de-rating. The firm's third-quarter earnings preview for the sector included these reductions.BenzingaStrategy Faces ‘Dilution Drag’ as TD Cowen Raises Bitcoin Forecast to $109,000 - Strategy (NASDAQ:MSTR)TD Cowen raised its Bitcoin forecast to $109,000 but kept its Strategy target at $260, citing dilution risk from debt and preferred shares. The analysts' model projects Bitcoin near $109,000 by end of 2026, climbing to $280,000 by 2029. Strategy's valuation is back to roughly one times net asset value.Ticker ReportTD Cowen Has Lowered Expectations for Howmet Aerospace (NYSE:HWM) Stock PriceTD Cowen lowered its price target for Howmet Aerospace from $320 to $280, keeping a buy rating. The stock closed at $224.87, with a consensus price target of $311.16. The company reported Q2 EPS of $1.33, beating estimates, and set Q3 2026 guidance at $1.34-$1.36.Ticker ReportLockheed Martin (NYSE:LMT) Stock Price Target Lowered at TD CowenTD Cowen lowered its Lockheed Martin price target to $570 from $600, keeping a hold rating. The aerospace firm reported Q2 EPS of $7.94, beating estimates, with revenue up 10.5% year-over-year. Analysts' consensus remains hold at $634.50.Markets DailyTD Cowen Has Lowered Expectations for Moog (NYSE:MOG.A) Stock PriceTD Cowen lowered its Moog price target to $440 from $450, keeping a buy rating. Moog reported Q2 EPS of $3.72, beating estimates, with revenue up 15.2% year-over-year. The stock closed at $365.58, trading up 0.7%.Markets DailyHexcel (NYSE:HXL) Stock Price Target Lowered at TD CowenTD Cowen lowered its Hexcel price target to $90 from $115, keeping a Hold rating. The consensus rating is Hold with a target of $105.17, and Hexcel reported Q2 EPS of $0.66, beating estimates. The stock traded at $85.26 on Friday.Markets DailyFiserv (NASDAQ:FISV) Price Target Cut to $49.00 by Analysts at TD CowenTD Cowen cut its Fiserv target price to $49 from $55, keeping a hold rating. The stock closed at $45.61, with an average analyst price target of $73.43. Fiserv reported Q2 EPS of $1.84, missing the $1.91 consensus.BenzingaHow to Earn $500 a Month From Goldman Sachs Stock Ahead of Q3 Earnings - Goldman Sachs Group (NYSE:GS)Goldman Sachs will report Q3 earnings before the opening bell on Oct. 13, with analysts expecting $13.51 per share and $16.99 billion revenue. TD Cowen initiated a Buy rating with a $1,050 price target. The stock closed at $882.59, and the article calculates that 300 shares would yield $500 monthly from the 2.27% dividend.StocktwitsCVS Stock: TD Cowen Warns Of Bottom-Line Pressure For CVS Health Amid Star Ratings SetbackTD Cowen warned that weaker 2027 Medicare Advantage Star Ratings could cut CVS Health's government bonus payments and reduce adjusted earnings by $0.41 per share in 2028. The brokerage expects adjusted EPS growth to slow by about 5%, though CVS could offset the impact by adjusting plan benefits.